Skip to main content
OpenTrials

Clinical trial condition

Fibrodysplasia Ossificans Progressiva

Explore clinical trials studying Fibrodysplasia Ossificans Progressiva. Study availability and eligibility vary by location and protocol.

12 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Fibrodysplasia Ossificans Progressiva trial results

Recruiting

A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

NCT06089616

Conditions
Fibrodysplasia Ossificans Progressiva, Muscular Diseases, Musculoskeletal Diseases, +2 more
Locations
  • The Regents of the University of California San Francisco, California, United States
  • The Trustees of the University of Pennsylvania, Office of Clinical Research-Legal Services, Perelman School of Medicine Philadelphia, Pennsylvania, United States
  • Edmonton Clinic Health Academy (ECHA)- University of Alberta Edmonton, Canada
  • Bone Research and Education Centre Oakville, Canada
View Trial Details
Completed

An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)

NCT02279095

Conditions
Fibrodysplasia Ossificans Progressiva, Muscular Diseases, Musculoskeletal Diseases, +5 more
Locations
  • University of California San Francisco, Division of Endocrinology and Metabolism San Francisco, California, United States
  • Mayo Clinic, Department of Medicine Rochester, Minnesota, United States
  • University of Pennsylvania, Center for FOP & Related Bone Disorders Philadelphia, Pennsylvania, United States
  • Hospital Italiano de Buenos Aires, Department of Pediatrics Buenos Aires, Argentina
View Trial Details
Completed

An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva.

NCT03312634

Conditions
Fibrodysplasia Ossificans Progressiva, Muscular Diseases, Musculoskeletal Diseases, +5 more
Locations
  • University of California San Francisco, Division of Endocrinology and Metabolism San Francisco, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • University of Pennsylvania, Internal Medicine Philadelphia, Pennsylvania, United States
View all 16 locations
View Trial Details
Completed

A Study to Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva

NCT03188666

Conditions
Fibrodysplasia Ossificans Progressiva, Muscular Diseases, Musculoskeletal Diseases, +2 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Vanderbilt University Nashville, Tennessee, United States
  • Toronto General Hospital Toronto, Ontario, Canada
View Trial Details
Completed

An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects

NCT02190747

Conditions
Fibrodysplasia Ossificans Progressiva, Muscular Diseases, Musculoskeletal Diseases, +5 more
Locations
  • University of California San Francisco, Division of Endocrinology and Metabolism San Francisco, California, United States
  • University of Pennsylvania, Center for Research in FOP & Related Disorders Philadelphia, Pennsylvania, United States
  • Hôpital Necker-Enfants Malades, Department of Genetics Paris, France
  • The Royal National Orthopaedic Hospital, Brockley Hill Stanmore, Middlesex, United Kingdom
View Trial Details
Completed

A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)

NCT02322255

Conditions
Fibrodysplasia Ossificans Progressiva, Muscular Diseases, Musculoskeletal Diseases, +5 more
Locations
  • University of California San Francisco, Division of Endocrinology and Metabolism San Francisco, California, United States
  • University of Pennsylvania, Center for FOP & Related Bone Disorders Philadelphia, Pennsylvania, United States
  • Hospital Italiano de Buenos Aires, Department of Pediatrics Buenos Aires, Argentina
  • Queensland University of Technology (QUT) Institute of Health and Biomedical Innovation (IHBI) Woolloongabba, Queensland, Australia
View Trial Details

Related conditions